Riskpilot← Back to searchSign inGet full accessÖmsesidighet AB
ABActiveOrg 5568100431Teknikgatan 18General medical practice activities · NACE 8621Est. 20100 employees
Revenue 2025
SEK 104K
-37% vs 2024
EBITDA margin
55.2%
-51% vs 2024
Equity ratio
94.4%
Financial strength
Net profit 2025
SEK 46K
-50% vs 2024
| Revenue | SEK 104K | -37% |
| EBITDA | SEK 57K | -51% |
| Net profit | SEK 46K | -50% |
| Total assets | SEK 637K | -29% |
| Equity | SEK 601K | -30% |
| Employees | 0 | — |
Legal name
Ömsesidighet AB
Org number
5568100431
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 juni 2010
Share capital
SEK 150 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Bengmark, Claes Thomas Svensson, Göran Hasse
Company purpose
Föremålet för bolagets verksamhet är att direkt eller indirekt bedriva vårdverksamhet samt därmed förenlig verksamhet.
Address
Teknikgatan 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 53 | 112 | 194 | 166 | 104 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 36 | 72 | 32 | 116 | 57 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 36 | 72 | 32 | 116 | 57 |
| Net financials | — | −1 | −0 | −0 | 1 |
| Profit before tax | 36 | 72 | 32 | 116 | 58 |
| Tax | −8 | −15 | −7 | −24 | −12 |
| Net profit | 28 | 57 | 25 | 92 | 46 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 768 | 771 | 796 | 899 | 637 |
| Equity | 680 | 737 | 762 | 855 | 601 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 87 | 34 | 34 | 45 | 36 |
| Total debt | 87 | 34 | 34 | 45 | 36 |
EBITDA margin
55.2%
This company
15.8%
Market median
+249% vs market
20212025
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20212025
Return on equity
7.7%
This company
18.4%
Market median
-58% vs market
20212025
Net profit margin
44.5%
This company
8.1%
Market median
+449% vs market
20212025
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ML Auditor Substitute | Auditor Substitute | 2022 |
SH Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ömsesidighet AB 
Stenblomman KommanditbolagBoard members of Ömsesidighet AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Louise Jonasson | Auditor Substitute | 0 companies |
| Sven Henrik Olsson | Audit | 0 companies |
| Göran Hasse Svensson | Board of Directors | 0 companies |
| Åsa Heléne Bengmark | Deputy Board Member | 0 companies |
| Claes Thomas Bengmark | Chairman | 0 companies |